Find the latest news from our company.
The award recognizes Evonik’s strong cell culture ingredients portfolio that includes cQrex® peptides, the plant-based cholesterol PhytoChol®, as well as R&D, formulation and process expertise. ... MORE
Evonik increases speed to market for drug developers working on nucleic acid therapeutics ... MORE
Evonik is transforming its Health Care business to focus on its strategic core growth areas. ... MORE
Evonik has won this year’s CPHI Pharma Award in the category “Sustainability”. The winning innovation is the plant-based squalene, PhytoSquene®, which can be used for parenteral drug delivery applications, and is the first plant-based squalene in GMP quality. ... MORE
The Global Competence Network brings together a multidisciplinary team of business, application technology and research and development experts in chemistry, cell biology, bioprocessing and media optimization across Asia, Europe and the Americas. ... MORE
Evonik is expanding its EUDRACAP® portfolio with a new functional, ready-to-fill capsule that enables the delivery of sensitive active ingredients to the ileo-colonic region. ... MORE
